Bookrunners JPMorgan and Citigroup, managers BMO, William Blair assist
By Devika Patel
Knoxville, Tenn., May 12 – aTyr Pharma, Inc. said the underwriters for its initial public offering of stock opted to exercise the deal’s $11.26 million greenshoe in full, lifting total proceeds of the offering to $86.3 million. The deal was announced April 6 and priced for $75.04 million with the greenshoe on May 6.
The company sold 6,164,000 common shares at $14.00 each. Of the shares, 804,000 were part of the fully exercised greenshoe.
J.P. Morgan Securities LLC and Citigroup Global Markets Inc. were the bookrunning managers.
Proceeds will be used for clinical trials, research, discovery, development, working capital and other general corporate purposes.
The biopharmaceutical company is based in San Diego. It has listed its common stock on the Nasdaq under the symbol “LIFE.”
| Issuer: | aTyr Pharma, Inc.
|
| Issue: | Common stock
|
| Amount: | $86,296,000, including $11,256,000 greenshoe
|
| Shares: | 6,164,000
|
| Price: | $14.00
|
| Bookrunners: | J.P. Morgan Securities LLC and Citigroup Global Markets Inc.
|
| Managers: | BMO Capital Markets Corp. (lead) and William Blair & Co., LLC (co-manager)
|
| Announcement date: | April 6
|
| Pricing date: | May 6
|
| Settlement date: | May 12
|
| Stock symbol: | Nasdaq: LIFE
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
